에이프로젠바이오로직스

003060KOSPISector: Pharma & Biotech

₩1,980▼ 0.05%Market cap ₩28.5BAs of Jul 21, 2026 close · updated once daily

Grade D33.4 ptsTop 81% of 2,523 stocks

Financial strength

18.0

Growth momentum

35.1

Price attractiveness

49.8

As of Jul 21, 2026 close · This grade is not a buy/sell recommendation — it is information mechanically scored from public data using a fixed formula.

Financial strength

18.0

How much debt does it carry relative to equity?

Debt-to-equity ratio

111.5%

✗ Below median · Top 79.5% in sector

Sector median 51.5%

Can it cover what's due within a year?

Current ratio

67.4%

✗ Below median · Top 86% in sector

Sector median 191.3%

How much of revenue becomes profit?

Operating margin

-82.4%

✗ Below median · Top 72.6% in sector

Sector median -2.3%

How much did it earn on its own capital?

ROE (return on equity)

-82.0%

✗ Below median · Top 90% in sector

Sector median -4.5%

Source filing: annual report (consolidated) — view original ↗

Growth momentum

35.1

How much did revenue grow in a year?

Revenue growth (YoY)

8.7%

✓ Above median · Top 41.8% in sector

Sector median 6.4%

Has it grown steadily over three years?

Revenue 3-year CAGR

4.0%

✗ Below median · Top 54.1% in sector

Sector median 4.9%

Did core profits grow in a year?

Operating income change (YoY)

-14.3%

✗ Below median · Top 66.7% in sector

Sector median 3.6%

Are core profits higher than three years ago?

Operating income change (3Y)

-1011.4%

✗ Below median · Top 97% in sector

Sector median 3.5%

Source filing: annual report (consolidated) — view original ↗

Price attractiveness

49.8

Is the price expensive relative to earnings?

P/E (price-to-earnings)

Loss-making (P/E not computable)

✗ Below median · Top 99.8% in sector

Sector median P/E of profitable peers 14.4x · 57% loss-making

Is the price expensive relative to book value?

P/B (price-to-book)

0.14x

✓ Above median · Top 0.6% in sector

Sector median 1.39x

Valuation uses the Jul 21, 2026 close and market cap

Grade distribution of 248 stocks in Pharma & Biotech

S1A52B66C51D61F15